Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives

被引：2
|
作者：
Blanchard, P. [1 ,2 ,3 ]
Bourhis, J. [4 ]
Lacas, B. [1 ,3 ,5 ]
Le Teuff, G. [1 ,3 ,5 ]
Michiels, S. [1 ,3 ,5 ]
Pignon, J. -P. [1 ,3 ,5 ]
机构：
[1] Gustave Roussy, Serv Biostat & Epidemiol, F-94800 Villejuif, France
[2] Gustave Roussy, Dept Radiotherapie, F-94800 Villejuif, France
[3] Univ Paris 11, CESP, INSERM, U1018, Villejuif, France
[4] CHU Vaudois, CH-1011 Lausanne, Switzerland
[5] Gustave Roussy, Plateforme Ligue Natl Canc Metaanal Oncol, F-94800 Villejuif, France
来源：
CANCER RADIOTHERAPIE | 2015年 / 19卷 / 03期
关键词：
Head and neck cancer; Chemotherapy; Radiotherapy; Meta-analysis; Randomized trials; Individual patient data; Network meta-analysis; Surrogate marker; LOCALLY ADVANCED HEAD; NASOPHARYNGEAL CARCINOMA; SYSTEMATIC REVIEWS; RADIATION-THERAPY; PUBLICATION BIAS; CHEMOTHERAPY; RADIOTHERAPY; CANCER; AMIFOSTINE; SURVIVAL;
D O I：
10.1016/j.canrad.2014.12.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Meta-analyses are considered as an important pillar of evidence-based medicine. The aim of this review is to describe the main principles of a meta-analysis and to use examples of head and neck oncology to demonstrate their clinical impact and methodological interest. The major role of individual patient data is outlined, as well as the superiority of individual patient data over meta-analyses based on published summary data. The major clinical breakthrough of head and neck meta-analyses are summarized, regarding concomitant chemotherapy, altered fractionated chemotherapy, new regimens of induction chemotherapy or the use of radioprotectants. Recent methodological developments are described, including network meta-analyses, the validation of surrogate markers. Lastly, the future of meta-analyses is discussed in the context of personalized medicine. (C) 2015 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：198 / 204
页数：7
相关论文
共 16 条
  • [1] Are Individual patient data meta-analyses still needed today in oncology? A discussion focused on Head and Neck oncology
    Blanchard, Pierre
    Auperin, Anne
    Pignon, Jean-Pierre
    ACTA ONCOLOGICA, 2019, 58 (10) : 1333 - 1336
  • [2] Understanding the Results of Meta-Analyses in the Treatment of Head and Neck Squamous Cell Cancer
    Hotte, Sebastien J.
    Wright, James R.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (06) : 1257 - +
  • [3] Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 39 randomized trials
    Aabo, K
    Adams, M
    Adnitt, P
    Alberts, DS
    Athanazziou, A
    Barley, V
    Bell, DR
    Bianchi, U
    Bolis, G
    Brady, MF
    Brodovsky, HS
    Bruckner, H
    Buyse, M
    Canetta, R
    Chylak, V
    Cohen, CJ
    Colombo, N
    Conte, PF
    Crowther, D
    Edmonson, JH
    Gennatas, C
    Gilbey, E
    Gore, M
    Guthrie, D
    Kaye, SB
    Laing, AH
    Landoni, F
    Leonard, RC
    Lewis, C
    Liu, PY
    Mangioni, C
    Marsoni, S
    Meerpohl, H
    Omura, GA
    Parmar, MKB
    Pater, J
    Pecorelli, S
    Presti, M
    Sauerbrei, W
    Skarlos, DV
    Smalley, RV
    Solomon, HJ
    Stewart, LA
    Sturgeon, JFG
    Tattersall, MHN
    Wharton, JT
    Huinink, WWT
    Tomirotti, M
    Torri, W
    Trope, C
    BRITISH JOURNAL OF CANCER, 1998, 78 (11) : 1479 - 1487
  • [4] Anti EGFR therapy in the treatment of non-metastatic head and neck squamous cell carcinoma: The current evidence
    Benson, Rony
    Mallick, Supriya
    Julka, P. K.
    Rath, G. K.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2016, 28 (03) : 141 - 148
  • [5] surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials
    Rotolo, Federico
    Paoletti, Xavier
    Michiels, Stefan
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2018, 155 : 189 - 198
  • [6] Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized clinical trials
    Dang, Shoutao
    Zhang, Shurong
    Zhao, Jingyang
    Li, Xinyu
    Li, Wei
    CANCER MEDICINE, 2023, 12 (20): : 20277 - 20286
  • [7] Treatment with (chemo)-radiation in old patients (≥76 years of age) with newly diagnosed non-metastatic squamous cell cancer of the head and neck region: real-world data from a tertiary referral center
    Winkler, Leah-Sophie
    Haderlein, Marlen
    Semrau, Sabine
    Putz, Florian
    Hoefler, Daniel
    Mueller, Sarina K.
    Iro, Heinrich
    Kesting, Marco
    Fietkau, Rainer
    Schubert, Philipp
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [8] Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
    Coleman, R.
    Powles, T.
    Paterson, A.
    Gnant, M.
    Anderson, S.
    Diel, I.
    Gralow, J.
    von Minckwitz, G.
    Moebus, V.
    Bergh, J.
    Pritchard, K. I.
    Bliss, J.
    Cameron, D.
    Evans, V.
    Pan, H.
    Peto, R.
    Bradley, R.
    Gray, R.
    Bartsch, R.
    Dubsky, P.
    Fesl, C.
    Fohler, H.
    Greil, R.
    Jakesz, R.
    Lang, A.
    Luschin-Ebengreuth, G.
    Marth, C.
    Mlineritsch, B.
    Samonigg, H.
    Singer, C. F.
    Steger, G. G.
    Stoeger, H.
    Olivotto, I.
    Ragaz, J.
    Christiansen, P.
    Ejlertsen, B.
    Ewertz, M.
    Jensen, M-B
    Moller, S.
    Mouridsen, H. T.
    Eiermann, W.
    Hilfrich, J.
    Jonat, W.
    Kaufmann, M.
    Kreienberg, R.
    Schumacher, M.
    Blohmer, J. U.
    Costa, S. D.
    Eidtmann, H.
    Gerber, B.
    LANCET, 2015, 386 (10001) : 1353 - 1361
  • [9] Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials
    Budach, Wilfried
    Boelke, Edwin
    Kammers, Kai
    Gerber, Peter Arne
    Orth, Klaus
    Gripp, Stephan
    Matuschek, Christiane
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 (02) : 238 - 243
  • [10] Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer
    Pujol, Jean-Louis
    Pirker, Robert
    Lynch, Thomas J.
    Butts, Charles A.
    Rosell, Rafael
    Shepherd, Frances A.
    Vansteenkiste, Johan
    O'Byrne, Kenneth J.
    de Blas, Barbara
    Heighway, Jim
    von Heydebreck, Anja
    Thatcher, Nick
    LUNG CANCER, 2014, 83 (02) : 211 - 218
12